相关实验视频

Updated: Jun 22, 2025

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Published on: October 30, 2018

增强神经网络菌:与衰老和APP毒性作斗争的战略

Wenqing Mou¹, Yixian Cui¹

¹Department of Neurosurgery, Medical Research Institute, Frontier Science Center for Immunology and Metabolism, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.

|July 4, 2024

概括

网膜化 (Reticulophagy) 是一种降解细胞内膜网膜成分的过程,对健康至关重要. 在果中增强这种过程对治疗神经退行性疾病和衰老有希望.

科学领域:

细胞生物学细胞生物学
神经科学是一个神经科学.
自学研究自学研究

背景情况:

网膜菌对于内细胞网膜 (ER) 质量控制至关重要,并与疾病有关.
电平稳定对细胞功能和生物体健康至关重要.

研究的目的:

用Drosophila建立一个体内模式用于网膜菌.
调查网膜在衰老和神经退行性疾病中的作用.

主要方法:

利用Drosophila作为一个体内模型系统.
在各种组织中操纵了网膜受体 (atl和Rtnl1) 的表达.
开发了一种表达人类粉样β前体蛋白 (APP) 的Drosophila阿尔茨海默病模型.

主要成果:

饥饿诱导的网膜菌发生在多个Drosophila组织中.
网球受体表达的改变会影响的健康.
增强的神经网络缩能减少与年龄相关的退化,并通过促进APP降解来缓解阿尔茨海默氏症模型中的神经退化症状.
功能性受体-Atg8相互作用对于治疗效益至关重要.

结论:

调节网膜化为治疗衰老和神经退行性疾病提供了潜在的治疗策略.
准网膜食可能有助于管理与ER蛋白积累相关的疾病.

关键词:

衰老的衰老衰老的衰老美国美国美国粉胺β前体蛋白质蛋白质的前体蛋白质.美国大西洋接收器接收器接收器接收器网膜化 (reticulophagy) 是一种可靠的方法.

更多相关视频

A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes

A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes

Published on: February 5, 2018

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

相关概念视频

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...